HIV/AIDS associated lymphoma
A Berhan, B Bayleyegn, Z Getaneh - Blood and lymphatic cancer …, 2022 - Taylor & Francis
Lymphoma is one of the hematologic malignancies that occur at a higher rate in human
immunodeficiency virus-infected individuals. It is one of the most frequent neoplastic causes …
immunodeficiency virus-infected individuals. It is one of the most frequent neoplastic causes …
Patient characteristics and outcome of CD20-positive HIV-associated lymphoma: A single-center KwaZulu-Natal, South African hospital 12-year retrospective review
N Rapiti, N Abdelatif, A Rapiti, MY Moosa - Journal of the Egyptian …, 2022 - Springer
Background Due to the high prevalence of HIV, HIV-associated lymphoma (HAL) is a
common malignancy in South Africa. However, there is a paucity of literature on HAL from …
common malignancy in South Africa. However, there is a paucity of literature on HAL from …
Diffuse large B-cell lymphoma treated with R-CHOP in a resource-limited setting in South Africa: a real-world study
Z Musimar, M Mpetani, JS Abramson… - The …, 2023 - academic.oup.com
Background Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-
Hodgkin's lymphoma worldwide and particularly in Africa, where the incidence of HIV is the …
Hodgkin's lymphoma worldwide and particularly in Africa, where the incidence of HIV is the …
Diffuse large B-cell lymphoma in the public-sector of Johannesburg, South Africa, in the era of widescale antiretroviral therapy use
J Vaughan, Y Perner, T Wiggill - JAIDS Journal of Acquired …, 2022 - journals.lww.com
Background: Diffuse large B-cell lymphoma (DLBCL) is a high-grade non-Hodgkin
lymphoma with increased incidence among people living with HIV-infection (PLWH) …
lymphoma with increased incidence among people living with HIV-infection (PLWH) …
Lymphoma in Sub-Saharan Africa: a scoping review of the epidemiology, treatment challenges, and patient pathways
OT Baissa, T Ben-Shushan, O Paltiel - Cancer Causes & Control, 2024 - Springer
Purpose Improving cancer outcomes in Sub-Saharan Africa (SSA) requires effective
implementation of evidence-based strategies. This scoping review maps the evidence on …
implementation of evidence-based strategies. This scoping review maps the evidence on …
Prognostic variables and 4-year survival outcomes in CD20 Positive AIDS-Related Lymphoma in the Anti-retroviral treatment era: A Retrospective Review from a …
N Rapiti, N Abdelatif, MYS Moosa - Plos one, 2022 - journals.plos.org
Objective To describe 4-year survival outcomes and assess the value of established and
additional relevant variables to predict complete response (CR), four-year progression-free …
additional relevant variables to predict complete response (CR), four-year progression-free …
[PDF][PDF] Book Chapter
N Rapiti - PLoS ONE, 2023 - academicreads.com
Objective: To describe 4-year survival outcomes and assess the value of established and
additional relevant variables to predict complete response (CR), four-year progression-free …
additional relevant variables to predict complete response (CR), four-year progression-free …
[HTML][HTML] A Newly Diagnosed Patient With Human Immunodeficiency Virus (HIV)-Associated Epstein-Barr Virus (EBV)-Positive Diffuse Large B-cell Lymphoma and …
M Daniel, J Patel, M Kamel, D Roy - Cureus, 2024 - ncbi.nlm.nih.gov
The link between the Epstein-Barr virus (EBV) and the development of certain types of
lymphomas in patients with human immunodeficiency virus (HIV) is of noteworthy clinical …
lymphomas in patients with human immunodeficiency virus (HIV) is of noteworthy clinical …
Management of lymphoma in a centre with high HIV and tuberculosis prevalence
FC Bassa - 2021 - scholar.sun.ac.za
Background The staging and management of patients with lymphoma (PWL) can be
challenging and is particularly so in environments of high HIV and TB prevalence such as …
challenging and is particularly so in environments of high HIV and TB prevalence such as …
The Impact of HIV Status on Clinical Profile and Survival Among Patients With Diffuse Large B Cell Lymphoma in a Resource-Constrained Setting in the Haart Era
NA Mabruk, S Nyagabona, N Dharsee, E Lugina - 2024 - researchsquare.com
Background: Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease
encompassing a wide range of lymphomas, making diagnosis and treatment difficult. DLBCL …
encompassing a wide range of lymphomas, making diagnosis and treatment difficult. DLBCL …